Abstract
Here, we show that the anaplastic thyroid carcinoma (ATC) features the up-regulation of a set of genes involved in the control of cell cycle progression and chromosome segregation. This phenotype differentiates ATC from normal tissue and from well-differentiated papillary thyroid carcinoma. Transcriptional promoters of the ATC up-regulated genes are characterized by a modular organization featuring binding sites for E2F and NF-Y transcription factors and cell cycle-dependent element (CDE)/cell cycle gene homology region (CHR) cis-regulatory elements. Two protein kinases involved in cell cycle regulation, namely, Polo-like kinase 1 (PLK1) and T cell tyrosine kinase (TTK), are part of the gene set that is up-regulated in ATC. Adoptive overexpression of p53, p21 (CIP1/WAF1), and E2F4 down-regulated transcription from the PLK1 and TTK promoters in ATC cells, suggesting that these genes might be under the negative control of tumor suppressors of the p53 and pRB families. ATC, but not normal thyroid, cells depended on PLK1 for survival. RNAi-mediated PLK1 knockdown caused cell cycle arrest associated with 4N DNA content and massive mitotic cell death. Thus, thyroid cell anaplastic transformation is accompanied by the overexpression of a cell proliferation/genetic instability-related gene cluster that includes PLK1 kinase, which is a potential molecular target for ATC treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 10148-10158 |
| Number of pages | 11 |
| Journal | Cancer Research |
| Volume | 67 |
| Issue number | 21 |
| DOIs | |
| Publication status | Published - Nov 1 2007 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. / Salvatore, Giuliana; Nappi, Tito Claudio; Salerno, Paolo; Jiang, Yuan; Garbi, Corrado; Ugolini, Clara; Miccoli, Paolo; Basolo, Fulvio; Castellone, Maria Domenica; Cirafici, Anna Maria; Melillo, Rosa Marina; Fusco, Alfredo; Bittner, Michael L.; Santoro, Massimo.
In: Cancer Research, Vol. 67, No. 21, 01.11.2007, p. 10148-10158.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma
AU - Salvatore, Giuliana
AU - Nappi, Tito Claudio
AU - Salerno, Paolo
AU - Jiang, Yuan
AU - Garbi, Corrado
AU - Ugolini, Clara
AU - Miccoli, Paolo
AU - Basolo, Fulvio
AU - Castellone, Maria Domenica
AU - Cirafici, Anna Maria
AU - Melillo, Rosa Marina
AU - Fusco, Alfredo
AU - Bittner, Michael L.
AU - Santoro, Massimo
PY - 2007/11/1
Y1 - 2007/11/1
N2 - Here, we show that the anaplastic thyroid carcinoma (ATC) features the up-regulation of a set of genes involved in the control of cell cycle progression and chromosome segregation. This phenotype differentiates ATC from normal tissue and from well-differentiated papillary thyroid carcinoma. Transcriptional promoters of the ATC up-regulated genes are characterized by a modular organization featuring binding sites for E2F and NF-Y transcription factors and cell cycle-dependent element (CDE)/cell cycle gene homology region (CHR) cis-regulatory elements. Two protein kinases involved in cell cycle regulation, namely, Polo-like kinase 1 (PLK1) and T cell tyrosine kinase (TTK), are part of the gene set that is up-regulated in ATC. Adoptive overexpression of p53, p21 (CIP1/WAF1), and E2F4 down-regulated transcription from the PLK1 and TTK promoters in ATC cells, suggesting that these genes might be under the negative control of tumor suppressors of the p53 and pRB families. ATC, but not normal thyroid, cells depended on PLK1 for survival. RNAi-mediated PLK1 knockdown caused cell cycle arrest associated with 4N DNA content and massive mitotic cell death. Thus, thyroid cell anaplastic transformation is accompanied by the overexpression of a cell proliferation/genetic instability-related gene cluster that includes PLK1 kinase, which is a potential molecular target for ATC treatment.
AB - Here, we show that the anaplastic thyroid carcinoma (ATC) features the up-regulation of a set of genes involved in the control of cell cycle progression and chromosome segregation. This phenotype differentiates ATC from normal tissue and from well-differentiated papillary thyroid carcinoma. Transcriptional promoters of the ATC up-regulated genes are characterized by a modular organization featuring binding sites for E2F and NF-Y transcription factors and cell cycle-dependent element (CDE)/cell cycle gene homology region (CHR) cis-regulatory elements. Two protein kinases involved in cell cycle regulation, namely, Polo-like kinase 1 (PLK1) and T cell tyrosine kinase (TTK), are part of the gene set that is up-regulated in ATC. Adoptive overexpression of p53, p21 (CIP1/WAF1), and E2F4 down-regulated transcription from the PLK1 and TTK promoters in ATC cells, suggesting that these genes might be under the negative control of tumor suppressors of the p53 and pRB families. ATC, but not normal thyroid, cells depended on PLK1 for survival. RNAi-mediated PLK1 knockdown caused cell cycle arrest associated with 4N DNA content and massive mitotic cell death. Thus, thyroid cell anaplastic transformation is accompanied by the overexpression of a cell proliferation/genetic instability-related gene cluster that includes PLK1 kinase, which is a potential molecular target for ATC treatment.
UR - http://www.scopus.com/inward/record.url?scp=35948980377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35948980377&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-07-1887
DO - 10.1158/0008-5472.CAN-07-1887
M3 - Article
VL - 67
SP - 10148
EP - 10158
JO - Journal of Cancer Research
JF - Journal of Cancer Research
SN - 0008-5472
IS - 21
ER -